Royalty Pharma makes a third offer for Elan
Royalty Pharma has returned to Elan for a second time with a renewed offer of an estimated $8bn (€6bn) as it remains intent on taking control of the Irish pharma...
Royalty Pharma has returned to Elan for a second time with a renewed offer of an estimated $8bn (€6bn) as it remains intent on taking control of the Irish pharma...